轻松健康2025年12月15日至12月18日招股，拟全球发售2654万股，其中香港发售占10%，国际发售占 90%，另有15%超额配股权，每股发售价22.68港元。预期股份将于2025年12月23日在联交所开始买卖。 公司提供健康相关及保险相关解决方案。根据沙利文报告，按2024年收入计，公司在中国数字综合健康 服务及健康保险服务市场排名第10位。公司为用户提供早期疾病筛查推广及咨询、健康检查及咨询、医 疗预约服务以及保健品销售等健康相关服务，同时通过互联网保险平台为用户提供健康保险产品机会。 集团与广东横琴粤澳深度合作区澳琴合鸣投资合伙企业(有限合伙)订立基石投资协议，澳琴合鸣按发售 价认购或促使其指定实体认购合共约人民币1亿元可购入的有关数目的发售股份。 假设超额配股权未获行使，全球发售所得款项净额将约为5.134亿港元。集团拟将全球发售所得款项净 额用于以下用途：约40.0%用于提升集团的品牌知名度、提高用户参与度及加强与业务合作伙伴的合 作；约20.0%用于医学研究和真实世界研究；约20.0%用于提升集团在AI及大数据领域的技术能力，以 便更广泛应用于集团的产品及服务；约10.0%用于拓展至更多地区及 ...

Core Viewpoint - QingSong Health Corporation is preparing for an IPO on the Hong Kong Stock Exchange, aiming to leverage its position as a leading provider of integrated health services and health insurance solutions in China [1][2]. Company Overview - QingSong Health Corporation is ranked 10th in China's digital integrated health services and health insurance market based on revenue for 2024, and 7th in the digital health services market [1][8]. - The company offers a variety of health-related services, including digital marketing, digital medical research support, comprehensive health service packages, and early disease screening promotion and consulting services [1][3]. Financial Performance - For the fiscal year ending December 31, 2024, the company's revenue was approximately RMB 9.45 billion, with a net profit of about RMB 0.1 billion [1][5]. - The revenue for the first half of 2025 was RMB 6.56 billion, with a net profit of RMB 0.86 billion [1][5]. - The company has shown a compound annual growth rate (CAGR) of 54.95% in revenue from 2022 to 2025 [5]. User and Insurance Metrics - As of June 30, 2025, the company had 168.4 million registered users, with annualized premium income from sold insurance products totaling RMB 4.93 billion [2]. - The annualized premium income from sold insurance products has decreased from RMB 13 billion in 2022 to RMB 4.93 billion in 2025 [2]. Market Context - The market for digital integrated health services and health insurance in China is projected to grow from RMB 727 billion in 2020 to RMB 2,365 billion in 2024, with a CAGR of 34.3% [7]. - The market is expected to reach RMB 7,485 billion by 2029, with a projected CAGR of 25.9% from 2024 to 2029 [7]. Competitive Landscape - Comparable companies in the industry include Ping An Good Doctor, Health 160, and Health Road, with varying market capitalizations and financial metrics [11]. - QingSong Health Corporation's recent fiscal year revenue of RMB 9.45 billion positions it competitively within this landscape [11]. Management Structure - The board of directors consists of eight members, including two executive directors, three non-executive directors, and three independent non-executive directors [12]. Shareholder Structure - Major shareholders include Yang through various entities controlling 38.94% of voting rights, IDG China with 12.89%, and Sunshine Insurance with 10.56% [14]. Financing History - The company has undergone seven financing rounds, with the most recent raising approximately $75 million in December 2019 [15].

Core Viewpoint - The article discusses the upcoming IPO of Qingsong Health Group, which has paved the way for its listing in Hong Kong after receiving approval from the China Securities Regulatory Commission. The company, previously known for its crowdfunding platform Qingsongchou, has shifted its focus towards comprehensive health services and insurance solutions [2][3][8]. Company Overview - Qingsong Health Group, founded by Yang Yin, initially gained recognition through its crowdfunding platform Qingsongchou, which helped families raise funds for medical expenses. The company has evolved from its original business model to focus on digital health services and insurance [3][8]. - Yang Yin, the founder and CEO, transitioned from a career in investment to entrepreneurship in 2014, leveraging the rise of mobile internet to create a platform that connects individuals in need of financial assistance with potential donors [7][8]. Business Model and Financial Performance - The company has positioned itself as a one-stop platform for digital health services and health insurance solutions, offering services such as screening, medical appointment services, and health products [11]. - Revenue figures for Qingsong Health Group show a growth trajectory, with revenues of RMB 393.6 million in 2022, RMB 489.96 million in 2023, and projected revenues of RMB 945 million for 2024. The adjusted net profits for the same periods were RMB 149 million, RMB 146 million, and RMB 8.44 million respectively [11][12]. - The insurance services, launched in December 2016, have contributed significantly to the company's revenue, accounting for 81.5% of total revenue in 2022, while health services have seen an increase in revenue contribution from 15.2% in 2022 to 65.3% in 2024 [12]. Market Position and User Base - Qingsong Health Group has established a substantial user base, with 170 million registered users and partnerships with 86 pharmaceutical companies, offering a total of 294 insurance products from 58 insurance partners [13]. - The company has completed eight rounds of financing, raising approximately $126 million, with notable investors including IDG Capital, Sunshine Insurance, and Tencent [13]. Industry Context - The crowdfunding model for medical expenses has faced increasing competition and regulatory scrutiny, leading companies like Qingsong Health and Waterdrop to pivot towards insurance and health management services to ensure sustainability and profitability [17]. - The regulatory environment has evolved, with new guidelines requiring platforms to ensure the authenticity of fundraising requests and manage funds through dedicated accounts, reflecting a shift towards greater accountability in the industry [17].